Hypocretin system and narcolepsy;Sistema hipocretinérgico y narcolepsia

Revista Medica de Chile

Volumn 137, Issue 9, 2009, Pages 1209-1216

  Arias Carrión, Oscar ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Human; Hypocretin 1; Narcolepsy; Sleep

Indexed keywords

NEUROPEPTIDE;

ARTICLE; CEREBROSPINAL FLUID; HUMAN; NARCOLEPSY; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMANS; NARCOLEPSY; NEUROPEPTIDES;

EID: 70450181120     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BAUMANN C.R., BASSETTI CL. Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol 2005; 4: 673-82.
2. NISHINO S. The hypocretin/orexin system in health and disease. Biol Psychiatry 2003; 54: 87-95.
3. PEYRON C., TIGHE D.K., VAN DEN POL A.N., DE LECEA L., HELLER H.C., SUTCLIFFE J.G., KILDUFF TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
4. DAUVILLIERS Y., BLOUIN J.L., NEIDHART E., CARLANDER B., ELIAOU J.F., ANTONARAKIS S.E. ET AL. A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q. Ann Neurol 2004; 56: 382-8.
5. NAKAYAMA J., MIURA M., HONDA M., MIKI T., HONDA Y., ARINAMI T. Linkage of human narcolepsy with HLA association to chromosome 4p13-q21. Genomics 2000; 65: 84-6.
6. MALIK S., BOEVE B.F., KRAHN L.E., SILBER MH. Narcolepsy associated with other central nervous system disor-ders. Neurology 2001; 57: 539-41.
7. MURILLOR-ODRÍGUEZ E., ARIAS-CARRIÓN O. Hipocretinas, péptidos asociados con la narcolepsia. Gac Med Mex 2007; 143: 421-5.
8. MIGNOT E., LAMMERS G.J., RIPLEY B., OKUN M., NEVSIMALOVA S., OVEREEM S. ET AL. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553-62.
9. HONDA Y., ASAKA A., TANAKA Y., JUJI T. Discrimination of narcoleptic patients by using genetic markers and HLA. Sleep Res 1983; 12: 254.
10. THANNICKAL T.C., SIEGEL J.M., NIENHUIS R., MOORE RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 2003; 13: 340-51.
11. HINZE-SELCH D., WETTER T.C., ZHANG Y., LU H.C., ALBERT E.D., MULLINGTON J. ET AL. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 1998; 50: 1149-52.
12. TANAKA S., HONDA Y., INOUE Y., HONDA M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep 2006: 29: 633-8.
13. BLACK J.L. 3RD, SILBER M.H., KRAHN L.E., AVULA R.K., WALKER D.L., PANKRATZ V.S. ET AL. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry 2005; 58: 504-9.
14. OVEREEM S., VERSCHUUREN J.J., FRONCZEK R., SCHREURS L., DEN HERTOG H., HEGEMANKLEINN I.M. ET AL. Immunohisto- chemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol 2006; 174: 187-91.
15. FREDRIKSON S., CARLANDER B., BILLIARD M., LINK H. CSF immune variables in patients with narcolepsy. Acta Neurol Scand 1990; 81: 253-4.
16. BLACK JL 3RD, KRAHN L.E., PANKRATZ V.S., SILBER M. Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Sleep 2002; 25: 719-23.
17. DE LECEA L., KILDUFF T.S., PEYRON C., GAO X., FOYE P.E., DANIELSON P.E. ET AL. The hypocretins: hypothalamus- specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 1998; 95: 322-7.
18. SAKURAI T., AMEMIYA A., ISHII M., MATSUZAKI I., CHEMELLI R.M., TANAKA H. ET AL. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
19. PEYRON C., TIGHE D.K., VAN DEN POL A.N., DE LECEA L., HELLER H.C., SUTCLIFFE J.G., KILDUFF TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
20. SAPER C.B., SCAMMELL T.E., LU J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437: 1257-63.
21. HAGAN J.J., LESLIE R.A., PATEL S., EVANS M.L., WATTAM T.A., HOLMES S. ET AL. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911-6.
22. NISHINO S., MIGNOT E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997; 52: 27-78.
23. LIN L., FARACO J., LI R., KADOTANI H., ROGERS W., LIN X. ET AL. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76.
24. CHEMELLI R.M., WILLIE J.T., SINTON C.M., ELMQUIST J.K., SCAMMELL T., LEE C. ET AL. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-51.
25. HARA J., BEUCKMANN C.T., NAMBU T., WILLIE J.T., CHEMELLI R.M., SINTON C.M. ET AL. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001; 30: 345-54.
26. GERASHCHENKO D., KOHLS M.D., GRECO M., WALEH N.S., SALIN-PASCUAL R., KILDUFF T.S. ET AL. Hypocretin-2- saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001; 21: 7273-83.
27. NISHINO S., RIPLEY B., OVEREEM S., LAMMERS G.J., MIGNOT E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
28. RIPLEY B., OVEREEM S., FUJIKI N., NEVSIMALOVA S., UCHINO M., YESAVAGE J. ET AL. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001; 57: 2253-8.
29. KANBAYASHI T., INOUE Y., CHIBA S., AIZAWA R., SAITO Y., TSUKAMOTO H. ET AL. CSF hypocretin-1 (orexin-A) con-centrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002; 11: 91-3.
30. THANNICKAL T.C., MOORE R.Y., NIENHUIS R., RAMANATHAN L., GULYANI S., ALDRICH M. ET AL. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-74.
31. PEYRON C., FARACO J., ROGERS W., RIPLEY B., OVEREEM S., CHARNAY Y. ET AL. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
32. ARIAS-CARRIÓN O., MURILLO-RODRÍGUEZ E., XU M., BLANCO-CENTURIÓN C., DRUCKER-COLÍN R., SHIROMANI P.J. Trans-plant of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep 2004; 27: 1465-70.
33. ARIAS-CARRIÓN O., DRUCKER-COLÍN R., MURILLO-RODRÍGUEZ E. Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci Lett 2006; 404: 93-7.